102
Archived articleThis is an archived article from 2025 - please note that any content within the article may be out of date.

Daily Stock Market Report (Tue 16th September 2025) - BRCK PGH POLN KIE STEM TRST

Good morning!

08:00 - Agenda is complete

14:07 - Report is complete


Spreadsheet accompanying this report: link (last updated to: 5th September).


Companies Reporting

Name (Mkt Cap)

RNS

Summary

Our view (Author)

Anglo American (LON:AAL) (£30.2bn)

Agreement with Codelco

Joint mine plan for Los Broncoes and Andina in Chile will unlock a further 2.7mt of copper production.

JTC (LON:JTC) (£2.3bn)

Interim Results

Rev +17%, adj net profit +10% to £35.4m. FY expectations unchanged. Offer talks continue.

PINK

Sigmaroc (LON:SRC) (£1.39bn)

Update in relation to the AMeLi project

ArcelorMittal withdraws from project to develop 3 net zero kilns. No material impact on forecasts.

Kier (LON:KIE) (£857m)

FY25 Results

Rev +3%, PBT +15% to £78.1m. Order book +2% to £11.0bn. FY26 currently slightly ahead of exps.

AMBER/GREEN (Roland - I hold)
Today’s results look strong enough and management have edged up guidance for the year ahead. However, my review of the balance sheet and cash flow statement suggest that progress with deleveraging was limited last year. I also take issue with the company’s calculation of free cash flow, which is significantly higher than my estimate.
Niggles aside, Kier does seem to be trading well with an attractive pipeline of infrastructure work, particularly in the water sector. With some reluctance, I am moving our view up by one notch to AMBER/GREEN to reflect today’s upgrade.

Trustpilot (LON:TRST) (£817m)

Half-Year Results

Rev +21%, PBT +45% to $3.7m. New £30m buyback. FY EBITDA margin to be ahead of exps.

AMBER (Roland) [no section below]
When Graham reviewed Trustpilot’s full-year results in March, he commented on operating leverage from rising revenue and “yet another earnings upgrade”.
Today we have more of the same, but I’m not sure if it’s enough to justify the current valuation. Trustpilot’s operating profit tripled last year to $5.8m, but that still only translated into an operating margin of 4.7%.
There’s not yet much evidence of economies of scale or network effects, either. Operating costs rose by 20% to $94m, representing 77% of sales (H1 24: 78%).
The outlook for the remainder of the year has been upgraded to maintain the improved EBITDA margin (14.6%) achieved in H1. Assuming revenue remains unchanged, that equates to FY adj EBITDA of c.$37m. From what I can see in secondary sources, previous expectations were c.$35m, so this is a useful upgrade. However, with the stock still trading on c.50x 2026 forecast earnings, growth here isn’t rapid enough for me to be positive. I’m going to mirror the StockRanks and downgrade our view by one notch to neutral today.

Harworth (LON:HWG) (£554m)

Interim Results

H1 total accounting return 1.1%, NAVps 215.5p. Expect improving land market.

Pollen Street (LON:POLN) (£527m)

Interim Results

AUM +35% to £6.1bn, fee-paying AUM +37% to £4.7bn. FY guidance reaffirmed.

GREEN (Mark)

Excellent performance in the Asset Management business with AUM up significantly, especially allocated AUM and therefore fee-paying. There looks to be more to come with another Private Equity round closed just after period end and they are currently raising for a Private Credit fund. H1 fees look to be exceptional, hence why this is an in-line statement with around 60% of FY EPS delivered in H1. The Investment Company performance is also a drag, with PBT lower here than the previous year. Given how good a deal PE funds often end up for the manager, I would rather they didn’t invest in their own funds, but this is probably a necessary part of raising external capital. While the investment side makes cash flows lumpy, I don’t see why the increase in AUM won’t lead to further EPS growth over the next few years and hence makes the 11x P/E and 6% yield look cheap.

I still have my doubts about the true value delivered by any Private Equity funds. However, it is also worth noting that buying up UK mid-caps on historically low multiples, towards the bottom of an economic cycle, and leveraging them up, probably isn’t a terrible strategy. As such, there is always a chance that their funds become a source of strong returns on top of the great asset management part of the business. I see no reason to change our positive view at this point in the cycle.

Porvair (LON:PRV) (£331m)

Nine Month Trading Update

Q3 trading was satisfactory. Market trends consistent with H1.

SThree (LON:STEM)

Q3 Trading Update

Group net fees -12% YoY. FY25 guidance unch for £25m PBT. New business is challenging.

SP -20%

BLACK/AMBER/RED (Mark)

Today’s big profits warning for FY26 means that I’m going for that downgrade that Graham almost went for last time. I agree with him that this may be one of the better companies for an eventual recovery. However, that recovery now looks even further away, and the risks that these issues are structural rather than cyclical are increasing.

Fintel (LON:FNTL) (£225m)

Half Year Results

Rev +18.6% (+4% organic). Adj EBITDA +17% to £11.2m, net debt £30m. Outlook in line with exps.

MJ GLEESON (LON:GLE) (£199m)

Full Year Results

Results in line with exps. Rev +5.9%, adj PBT -11.7% to £21.9m. Outlook for FY26 “robust”.

City of London Investment (LON:CLIG) (£196m)

Final Results

FUM +6% to $10.8bn, net outflows $974m. PBT +15% to $26.0m. Dividend held at 33p.

Brickability (LON:BRCK) (£173m)

AGM Statement

YTD trading in line with exps. Despite challenging market, FY adj EBITDA guidance unch.

AMBER/GREEN (Mark - I hold)

A short in-line AGM statement would normally be non-news. What makes this interesting is that the recent share price implied that a warning was on the way, and the valuation metrics look compelling for a business trading in such difficult macro conditions. We have to wait for the end of October to see some actual figures for the Half Year, but in the meantime I see little reason to change our positive view.

Eleco (LON:ELCO) (£132m)

Interim Results

Rev +13%, ARR +19%. Adj PBT +23% to £2.7m. Good progress. FY outlook in line with exps.

EKF Diagnostics Holdings (LON:EKF) (£130m)

Half-Year Report

Rev unch, PBT +16% to £3.6m. Analyzer prod +60%. FY25 adj EBITDA to be in line with exps.


Personal group (LON:PGH) (£116m)

Interim Results

Rev +11%, PBT +68% to £3.8m. Strong insurance sales cont’d in Q3. FY outlook in line with exps.

AMBER/GREEN (Roland - I hold)
These results look positive to me and do not seem to raise any obvious concerns. I don’t see any reason to doubt the full-year outlook and would guess there could be a little bit of upside to come if H2 remains strong.
However, I think it’s worth noting that there’s no strong trend of upgrades here and the group’s 2030 targets rely on doubling annual revenue and achieving a material increase in profitability. For now, I think the shares look reasonably valued and remain happy to hold (in SIF), especially given the more generous dividend payout. Our view remains unchanged today.

Springfield Properties (LON:SPR) (£108m)

Final Results

Rev +5.3%, PBT +96% to £19.0m. Completions -9% to 799. Expects underlying rev growth in FY26.


Focusrite (LON:TUNE) (£97.4m)

Trading Update

Rev for 6m to 31st Aug +6.6% to c£87m, gross margins improved slightly, net debt c£11m, “The Board continues to expect Adjusted EBITDA for the 12 months to 31 August 2025 to be within the current range of market forecasts.”


NWF (LON:NWF) (£85.8m)

AGM Statement and Trading Update

“…the Board's outlook for the full financial year is unchanged.”


Eagle Eye Solutions (LON:EYE) (£79m)

FInal Results

FY Revenue flat at £48.2m, Adj. EBITDA +8% to £12.2m, PBT +315% to £3.0m. Net cash £12.3m (FY24: £10.4m)


Headlam (LON:HEAD) (£53m)

Half-Year Results

H1 Revenue -4.6% to £244.7m, u/l LBT £19.9m (24H1: LBT £15.6m), Net debt £24m (24H1: £28.3m), “market data indicates a slight deterioration in market conditions in the last three months”


Manolete Partners (LON:MANO) (£50m)

AGM Update

“In the period to 31 August 2025, 114 new cases have been added which have generated unaudited unrealised revenue of £4.2 million….Over the last 12 weeks the Company has settled fewer large cases than in the prior year period. In the five months to 31 August 2025, four cases settled at a value greater than £250,000 compared to ten in the same period last year.” Loan facility drawn to £12.5m.


Corero Network Security (LON:CNS) (£47m)

Interim Results

Revenue -10% to $10.9m, order intake -12% to $12.5m, LBITDA $1.4m (24H1: EBITDA $0.7m). Comfortable with FY guidance of $24.0- 25.5m revenue and LBITDA between $1.5 - 0m.


Manx Financial (LON:MFX) (£43m)

Conister Bank enters into an agreement with Fiinu

“The Bank has signed a Master Services Agreement with AIM traded Fiinu for a minimum three-year exclusivity period to integrate Fiinu's overdraft technology into its product suite.”


tinyBuild (LON:TBLD) (£38.7m)

Half Year Results

Revenue flat at $17.0m, Adj. EBITDA $4.2m (24H1: LBITDA $2.3m), Cash $4.6m (31 Dec: $3.1m) after disposal of Red Cerberus for $1.0m.


Ariana Resources (LON:AAU) (£33.3m)

Summary of Projects

Listed on ASX raising A$11m, Dokwe Gold Project in Zimbabwe continues to be advanced through its DFS, new diamond and RC drilling programme of 11,000m at Dokwe; with drilling to commence in early October.


Kromek (LON:KMK) (£32m)

Final Results

Revenue +37% to £26.5m, adjusted EBITDA +232% to £10.3m, PBT significantly ahead of market expectations at £3.1m (2024: £3.5m loss),Cash £1.7m (30 April 2024: £0.5m) with $5m received post year end.

FY26 trading in line with market expectations.


Powerhouse Energy (LON:PHE) (£27m)

Half-Year Report

Revenue +23% to £475k, LBT £1.84m (24H1: LBT £1.17m) Cash £1.47m (30 June 24: £2.73m) after £1.375m raise in the period.


Mast Energy Developments (LON:MAST) (£24.9m)

AI Datacentre Power Supply Strategy

Targeting 1GW by 2030.

In advanced discussions with a datacentre developer and owner regarding a 25 MW datacenter development.


Corcel (LON:CRCL) (£22.5m)

Award of Seismic Acquisition Project

To acquire 326-line km of 2D seismic data over the KON-16 block, onshore Angola


OptiBiotix Health (LON:OPTI) (£10.6m)

Half-year Report

Revenue +102% to £557k, LBT £1.18m (24H1: LBT £2.79m), Cash £1.30m (24H1:1.26m)


Pennant International (LON:PEN) (£9.73m)

Subscription to raise £1.25m / Interim Results

Placing: £1.25m gross raised at 22.5p, a 4.4% discount, used to reduce overdraft.

Results: Revenue -39% to £4.5m, Adj LBT £1.8m (24H1: £0.2m), net debt £2.1m (24H1: £1.6m), after £3.1m property sales.

Outlook: “..the Group is currently trading in line with current market expectations.”



* Market caps at previous trading day’s close


Mark’s Section:

Brickability (LON:BRCK)

Up 4% at 55p - AGM Statement - Mark (I hold) - AMBER/GREEN

A short in line AGM statement wouldn’t normally garner much interest. However, in this case it seems that trading in line with the board’s expectations may actually exceed market expectations. Not those of the broker, that have remained pretty flat since March:

a03a6d66-843d-467a-a51d-715c7155fc83.png

But the expectations of investors, who have not wanted to hold the equity into this trading statement:

63f8d5cd-03ec-42a2-aedd-5dd94130d41c.png

bf2c86a5-d599-43f3-9d8d-404918dd52c6.png

Perhaps not surprising when this is the market backdrop as described by the company::

Notwithstanding the challenging market conditions, predominantly driven by a slow pace of recovery in housing starts and RMI together with the delays in approvals by the Building Safety Regulator (BSR)...

So they are managing the situation well to report “the Board's expectations for adjusted EBITDA(*) for the full year remain unchanged.” Of course, Adjusted EBITDA places a large emphasis on the adjustments, and it bears reminding ourselves of the scale of the adjustments they have historically made:

746d07ef-26cd-4a25-a8d7-5595df054043.png

Although sizeable, most of these I consider reasonable and either genuinely one-off or non-cash. Perhaps only ongoing “Business change project costs” should be added back in, in my opinion.

Their broker Cavendish haven’t issued an updated note this morning. Presumably, as nothing has changed. This makes the valuation metrics a sea of green:

83d4f003-c55b-490d-8924-27eaae8d762d.png

This makes this company look great value, especially as these represent a period of difficult end market conditions, with the company saying:

We remain confident in the Group's ability to deliver long-term shareholder value, with the business well positioned to benefit quickly as market demand incrementally improves towards more normalised levels.

Given that they have taken on debt to make acquisitions, it would have been nice to get an update on the current leverage. Although, they haven’t provided any other figures with this AGM update so it isn’t a specific omission. I expect a fuller picture when they release H1 trading figures at the end of October.

Mark’s view

I bought a small position here recently, as it looked just too cheap on current forecasts for a business operating in difficult market conditions. However, I was put off increasing my holding by the continuing sell off in the shares. At £170m market cap, it is possible that institutions are seeing something I was not, and an upcoming trading statement added to the risk. Having had in line trading confirmed, it seems now may be a good time to consider bringing it up to a full position, although I would also like to see some actual figures, which requires waiting until the end of October. Roland rated this AMBER/GREEN after the FY25 results were released in July. I see no reason to change that view today.

Pollen Street (LON:POLN)

Up 2% at 893p - Interim Results - Mark - GREEN

I’ve never been a fan of Private Equity. A lot of the supposed outperformance of such funds appears to come from the idea that such funds are less volatile than direct equity investments. Which is true, but only because they mark-to-model (make-believe), not to-market. In a recent FT article, fund manager Dan Rasmussen describes them as “a money trap for institutions” and highlights the danger institutions are in that have overallocated to this asset class. (Dan goes into a deeper dive of what the issues are surrounding this asset class on the Excess Returns podcast here.)

However, just because Private Equity doesn’t look like a great deal for institutional investors, it doesn’t mean it isn’t a great deal for those providing PE funds, such as Pollen. These results highlight this. Not only is this a rare fund manager that is growing AUM rapidly:

53463d76-4c7b-4103-adbb-e34d6fdae2f4.png

And in particular, fee-paying AUM, where they have deployed the committed capital:

98995629-cc98-4e50-9d01-1490ea604803.png

Not only are they able to grow AUM much faster than typical fund managers at the moment, but they can charge much more:

d2a7a021-fce1-4edd-8876-1732a1840422.png

They do point out that some of this is exceptional:

The Group has provided long-term guidance for a blended management fee rate across Private Equity and Private Credit of between 1.25 per cent and 1.5 per cent. The rate for H1 2025 exceeded this range at 1.76 per cent (H1 2024: 1.26 per cent), primarily due to the high level of catch-up fees earned in relation to Private Equity Fund V. No further catch-up fees are expected in relation to Private Equity Fund V, with the final close of that fund having been completed in July. Excluding the £8.4 million of catch-up management fees recognised in the period, the underlying Management Fee Rate would have been 1.37 per cent for H1 2025.

But in a world where fees are under constant pressure, they must be doing something right (or at least good at selling the idea that they will generate high performance.) One of the risks with fund managers is that all of the upside goes to the “star“ managers in the form of bonuses. However, here there are signs of significant operational gearing, with admin costs growing much more slowly than income:

37349166-1a54-432a-8e4f-2732362e6cda.png

This is helped by their ability to also claim some of the interest income received on unallocated funds:

In addition to management fees, the Group earns performance fees and carried interest, enabling it to share in the profits generated by its managed funds. These amounts are variable and depend on performance exceeding specific return thresholds ("hurdles") over the life of each fund. The Group is entitled to 25 per cent of carried interest across all Private Equity funds from Private Equity Fund IV onwards, and all Private Credit funds from Private Credit Fund III onwards.

Income should grow further as post-period end, as they have closed on an additional private equity fund:

In Private Equity we completed the successful final close of our flagship Fund V in July, securing commitments of €1.5 billion, exceeding our initial €1 billion target. Including associated co-investment vehicles, the Group has raised more than €2 billion in total equity capital for this flagship strategy. This fundraise attracted a range of new Limited Partners and broadened our investor base across North America and Europe, underscoring the deep and sustained confidence from a global base of institutional investors.

And have commitments towards their target for an additional private credit fund:

Private Credit IV also achieved strong AuM growth with £0.6bn in commitments closed at the end of June. We have a robust and advanced pipeline of investors which gives us visibility on achieving our initial £1 billion target during the course of the year. This success in fundraising is underpinned by the long-term relationships we build with our investors, something that we have supported through ongoing investment in our Investor Relations team.

Things aren’t so strong within the investment part of the business, which seems to invest in its own funds:

4b34af61-f7c0-4ce0-97ea-81529818f91f.png

They explain this as:

Underlying Investment Company returns for H1 were in line with expectations with an Underlying Net Investment Return of 8.8 per cent. The Reported Net Investment Return of 8.4 per cent (H1 2024: 9.7 per cent) was impacted by equalisation effects on investments in our Private Equity and Private Credit funds, reflecting the strong fundraising in the period, and a lower weighting of equity gains during H1 than is expected for H2.

Investing in one's own funds is normal in the fund management industry, with the manager often providing seed capital to develop an investment track record or to show confidence in a strategy/fundraise. However, with these being private equity and private credit funds, the same concerns about the real underlying returns of the funds and access to capital apply equally to Pollen’s own invested funds as they do to third-party investments. This is never really a tangible asset play, so these concerns may be lower than elsewhere:

236fcac1-b0c8-46d7-ad3e-0322c129d609.png

And while the equity investments may be funded out of cash flow, the bulk of the credit investment additions have been funded through realisations from earlier funds:

f9b327f8-f795-42dc-ba29-95bfa04ec076.png

However, the reduced profit from the Investment Company does take the shine off the excellent performance of the Asset Manager:

41639e9a-3e57-4795-9a0f-f293ceb3049a.png

Looking at the cash flow statement, I see that these dynamics mean that net cash from operating activities is just £9.7m compared to the £27.9m PAT. In 24H1, they had significant cash inflows, as they received a large distribution from one of the credit funds, so the cash flow isn’t all one way. However, it does highlight that investing capital in new funds appears to be a cost of growing AUM, and that cash flows will be lumpy. This is probably why the interim dividend payment is effectively held:

The Board is pleased to confirm an interim dividend for the period ended 30 June 2025 of 27.0 pence per share, amounting to a total payment of £16.3 million (H1 2024: dividend of 26.5 pence per share, amounting to a total payment of £16.5 million).

This still represents a yield of over 6%, and highlights that apart from the need to occasionally invest in their own funds, this is a very capital-light business. There is no research on Research Tree, but the consensus on Stockopedia is for 78.2p EPS. So, with a forward P/E of 11, this is also modestly rated for a company that is growing AUM and performance fees. Having delivered 46p in H1, it is tempting to think they may beat expectations. However, there are good reasons to believe that H2 will be a bit weaker than H1, and hence just in line:

Fund Management Income for H2 is expected to be lower than for H1 given the benefit of catch-up fees received in H1. Fee-paying AuM will continue to grow as a result of further capital raises in Private Credit Fund IV and their subsequent deployment. Investment Company investment returns for the full year are expected to be in-line with the returns delivered in FY24, continuing our long track record of delivering stable and robust performance from our balance of direct positions and investments in Pollen Street managed funds. The Group is trading in line with expectations.

Mark’s view

Being a Private Equity manager is a brilliant business and such a good deal for the manager, that the irony is that I wish they didn’t invest in their own funds! However, this appears to be a necessary feature of the industry as it gives confidence to investors that their interests are (somewhat) aligned. Compared to the asset manager part of the business, the Investment Company returns are currently a drag on the overall growth of the business, and mean cash flows are somewhat lumpy, with realisations and reinvestment timelines not always aligned. This is probably why the dividend growth isn’t matching the growth in profits in the short term.

However, there appears to be further growth ahead for the asset manager from the recently closed PE fund and an additional private credit fund currently raising capital. Plus, they will continue to deploy the assets they have under management. While fee levels in H1 look to be exceptional, there seems to be no reason why their annual EPS shouldn’t continue to grow from here, making them look good value, while paying a 6%+ dividend.

I still have my doubts about the true value delivered by any Private Equity funds. However, it is also worth noting that buying up UK mid-caps on historically low multiples, towards the bottom of an economic cycle, and leveraging them up, probably isn’t a terrible strategy. As such, there is always a chance that their funds become a source of strong returns on top of the great asset management part of the business. I see no reason to change our GREEN view at this point in the cycle.

SThree (LON:STEM)

Down 20% at 149p - Q3 Trading Update - Mark - BLACK/AMBER/RED

NFI seems in line with trends elsewhere amongst the large/mid-cap recruiters:

Group net fees down 12% YoY(1), with a modest sequential improvement quarter-on-quarter in Q3 supported by a return to growth in the US during the period.

Interestingly, here it is contract recruitment that is doing worse:

Contract (83% of net fees) down 13% YoY, whilst Permanent down 5% YoY.

This is in contrast to many recruiters, where permanent recruitment in an uncertain economic climate has been the biggest source of pain. This may well reflect SThree’s focus on the contractor market, or its technology specialism. These are actually a slight improvement on recent trends, especially for permanent recruitment:

6324b939-6845-4961-9394-ff9778aba09d.png

Both Germany and the Netherlands saw declining trends, the Uk was bumping along the bottom, while only the US and Japan grew:

0d827ea9-509d-4fd7-a989-34535e1b4623.png

They say that this is inline with guidance overall:

Performance for FY25 expected to be in line with previously announced £25 million PBT guidance

However, the real damage is to FY26:

Persistent softness in new business activity is expected to impact FY26 PBT consensus(5) by c.£20 million due to the Group's operational gearing. This alongside our investment initiatives, which are fully funded through careful cost management in FY25, is expected to result in a FY26 PBT of c.£10 million.

This is huge downgrade for a year that was meant to be a year of recovery:

74cd6bd1-1921-45e4-be4f-3be48dafe390.png

I’m not sure the statement gives us the full picture. If this is about investment and this is being fully funded by cost-down elsewhere in FY25, how come this impacts FY26 so severely?

Unsurprisingly, it is AI that’s requiring the investment:

Our tech-enabled model gives us the platform to invest in agentic AI functionality, to deliver quality STEM candidates quicker and more efficiently, which when coupled with certain investment initiatives and further cost optimisation, will result in a stronger, more agile business. Together with our specialist expertise in delivering STEM workforce solutions, we have the digital foundations, scale, and differentiated value proposition to be the market leader in an evolving STEM talent landscape.

But this in itself may be problematic. Candidates are using AI to complete CVs or recruiters applications or tests. Then the recruiters are using AI to screen applicants and do initial rounds in the name of efficiency, but with the use of AI all round, no one is quite sure if they are actually getting a good match. I have heard stories of employers recruiting for technical roles and after short-listing three candidates for interview, only one turns up; the other two turn out to be AI bots that have been programmed to appeal to the AI recruitment process. Of course, the big question is what’s the point? Well the bot programmers are clearly hoping there would be no in person/Zoom interview for remote roles and the bots would be able to do most of the job for a professional salary. Given the ease of trying this out, there is little cost to rolling the dice. The real cost is borne by the company that accidentally hires an AI bot, or has to run multiple recruitment processes for the same job.

Specialist recruitment used to be a people business. A specialist recruiter knew all the qualified candidates for a role, or the right questions to ask a new candidate and then only put suitable candidates forward. It was effective, but inefficient, so companies resented paying the high fees to find a candidate, or contractors resented giving away an ongoing chunk of their fees. The answer was to automate as much of the process as possible, but that automation leaves the process open to automation on the candidate side of the process. I don’t see any easy way out of this.

At these levels, TBV may be providing some support:

b6a6fe9b-4259-4f7c-b915-a28d21da5636.png

But this doesn’t speed up any eventual recovery, that now looks a long way away.

Mark’s view

When Graham looked at this in July, he said:

I think I can (just) maintain my AMBER stance on this for now, but if we interpret today’s share price reaction and the implied H2 PBT weighting as precursors to a full-blown profit warning, AMBER/RED might be more appropriate.

Today’s big profits warning for FY26 means that I’m going for that downgrade. I agree with Graham that this may be one of the better companies for an eventual recovery. However, that recovery now looks even further away, and the risks that these issues are structural rather than cyclical are increasing.


Roland’s Section:

Personal group (LON:PGH)

Unch at 371p (£116m) - Interim Results - Roland - AMBER/GREEN

(At the time of publication, Roland has a long position in PGH.)

Today’s half-year results from this workforce benefits and insurance provider seem to read well, with a big increase in profits and a shift to a generous 100% dividend payout ratio.  Even so, guidance is unchanged today and the market reaction has been underwhelming. It seems investors may have been expecting an upgrade today, after a run of strong momentum that’s seen the stock double over the last year:

c84f87cb-34c4-45a7-ac5f-c5c8b74e92c8.png

Interestingly, the StockRanks have turned a little cooler on this stock since July’s trading statement triggered a share price surge. I would take this as a reflection on weaker value credentials:

58bc1e71-6901-4245-9abb-b2c164452800.png

Let’s take a look at the results to see if they highlight any concerns.

H1 results summary

Revenue for the half year rose by 11% to £23.3m, with recurring revenue rising by 12% to £45.7m on an annualised basis. This supported a 68% increase in pre-tax profit to £3.8m – although note this still implies a (typical) H2 weighting to results. Reassuringly, the group reported growth across all three of its operation segments, following the disposal last year of the loss-making Let’s Connect unit:

  • Insurance annualised premium income +12% to £38m
  • Benefits Platform annual recurring revenue (ARR) +10% to £6.9m
  • Pay & Rewards ARR +6% to £0.76m

These support a 78% increase in earnings per share to 9.6p, while strong cash generation left the net cash position broadly unchanged at £26.9m (nearly a quarter of the market cap). This cash generated interest of £662k in H1, or 17% of pre-tax profit. A useful boost. This level of interest is equivalent to around 4.9% annualised on £27m, suggesting the company’s treasury management function is doing a good job.  This cash–rich situation has prompted management to adopt a more generous dividend policy:

For FY2025 and going forward, the Group now intends to pay dividends equivalent to approximately one times basic earnings per share for the full year, confident that a progressive dividend can be maintained on this basis.

Targeting a 100% payout ratio and a progressive policy implies management expects earnings per share to rise annually, indefinitely. Statistically this is unlikely to be true, but given the strong cash position and positive near-term outlook I can see why the payout has been increased. Personal Group has historically been a high-yielding stock, but recent strong share price growth has seen the yield drop to its lowest level since the 2021 market boom:

10a49f69-2845-4674-828b-d15feabb7794.png

On a side note, I’m happy to see some surplus cash actually being returned to shareholders, rather than passed to sellers through buybacks. Personal Group is a member of my SIF portfolio, which has an income mandate, so this focus on cash distribution is especially welcome.

Insurance: this business generates the majority of revenue and profit so deserves a closer look.

Insurance revenue rose by 13% to £17.4m, while adjusted EBITDA was 25% higher at £6.6m – a 38% margin. The company says claims levels were “broadly consistent year on year” and reports customer retention of over 80%. Penetration rates at existing clients rose to 13.7%, from 13% previously, thanks to “increased field force efficiency”, training and recruitment – this is a product that’s sold face-to-face. I have some lingering doubts about the value this business offers to end users, given its high profitability. But there’s no doubt that health insurance generally is a growth sector at the moment in the UK, so this could support a further increase in penetration rates among large clients.

To expand its reach and perhaps offer a more compelling value proposition, Personal Group is currently developing new “Group Cash Plan” and “Digital Insurance” services which it says are progressing well. I wonder if these could be lower margin services – and if so, whether there might be some cannibalisation from the core insurance offering.

Benefits & Rewards: this is a digital benefits platform providing employees with access to a range of benefits through an integrated online service (Hapi).

Sales cycles with large clients are described as “protracted”, but revenue rose by 5% to £4.0m, or £6.9m annualised. Revenue is generated from client subscriptions and commissions received from third-party suppliers on the platform (when end users purchase a service or product). Margins appear attractive here too, as this segment generated a 14% increase in EBITDA to £2.4m in H1. That’s a 60% EBITDA margin!

One important element of this is the partnership with Sage (disc: I hold), which allows the platform to be offered through Sage’s Employee Benefits offering. In an effort to reach more smaller companies, Personal also partnered EB Now in H1, “an employee benefits provider for the SMB market”.

Outlook & Estimates

Trading so far in H2 is said to be strong and CEO Paula Constant says new wins during the first half of the year have “expanded our addressable customer base and laid the foundations for continued growth”. However, expectations for the full year are unchanged, despite a strong start to H2:

Pleasingly, we have seen a continuation of the strong new insurance sales into H2 2025, with retention rates remaining robust. This combined with the Group's growing proportion of recurring revenues underpins the Board's confidence in achieving market expectations for the full year.

Broker Canaccord Genuity has kindly made updated forecasts available on Research Tree today and confirms unchanged revenue forecasts and minimal changes to profit expectations:

  • FY25E EPS: 20.1p (prev. 19.7p)
  • FY26E EPS: 24.9p (unch)

The dividend forecasts for FY25 is increased to 20.6p (prev. 18.0p), giving a prospective yield of 5.7%.

Roland’s view

I can’t really fault these results. Personal Group appears to be executing well and delivering on its plans. Meeting forecasts in the current market environment is hardly a major disappointment. On balance, I think the tone of today’s results suggests there could be a little upside to forecasts this year. However, this year’s forecast EBITDA of £11.6m remains a long way from the group’s 2030 target:

Underpinning the Group's success is the quality and relevance of our offerings, with the macroeconomic environment creating a growing market need, with employers increasingly recognising the importance of insurance cover and for their employees. We see considerable room for growth ahead and have line of sight to achieving our 2030 ambitions of delivering at least £100m revenue, £30m EBITDA and £20m SaaS ARR.

Forecasts for FY25 imply an EBITDA margin of 24% – well below the 30% margin implied by the 2030 targets above. Personally, I wonder if the company will be able to achieve the level of growth required to meet these targets while maintaining the current level of profitability in insurance.

After a strong run, I’m not entirely surprised to see today’s cool reception from the market. Earnings expectations have remained largely unchanged over the last 18 months, so it’s natural for the stock’s re-rating to slow at some point:

7a6d026f-736b-4061-8d44-9c342dc5a52c.png

On balance, my view remains broadly favourable here. I don’t think the shares are the bargain they were 12 months ago, but the valuation doesn’t seem unreasonable to me for a business generating 20%+ returns on equity and holding surplus cash. AMBER/GREEN.

Kier (LON:KIE)

Up 5% at 202p (£904m) - FY25 Results - Roland - AMBER/GREEN

(At the time of publication, Roland has a long position in KIE.)

I took a neutral view on this construction group (which is also a member of my SIF rules-based portfolio) when it issued an in-line trading update on 3 June.  It looks like perhaps I was too cautious. Kier shares have risen by more than 20% since then and remain rated as a Super Stock by the Stockopedia algorithms:

87aacf47-e2e3-49aa-8c8d-e438563f98be.png

Today’s full-year results are in line with expectations, but include an all-important upgrade to expectations for the year ahead. Let’s take a look.

FY25 results summary

All of the group’s main headline numbers moved in the right direction last year:

  • Revenue up 3% to £4,087.8m
  • Adjusted pre-tax profit up 6% to £125.4m
  • Reported pre-tax profit up 15% to £78.1m
  • Average month-end net debt: £49.2m (FY24: £116.1m)
  • Year-end order book +2% to £11.0bn

Shareholders will be rewarded with a 38% increase to the full-year dividend, which rises to 7.2p per share (3.5% yield).

Management reports “strong operational delivery across all businesses” and I think it’s fair to say the group’s three-pronged strategy probably is helping the business grow while reducing volatility in group profits.

Infrastructure: revenue rose by 7% to £2,136m, but adjusted operating profit was slightly lower at £111.0m (FY24: £112.3m). This saw divisional operating margin fall to 5.2%, from 5.6% in FY24.

Management says the fall in profit was due to a one-off gain last year and points to strong demand from water utilities as the AMP-8 investment cycle gathers pace.  Kier’s infrastructure business has a £6.5bn order book, with 87% of revenue secured for FY26.

Construction: revenue was almost unchanged at £1,911m, but the completion of some lower-margin government contracts helped to support an 8.4% increase in operating profit to £75.0m.

This pushed up the segmental margin to 3.9% (FY24: 3.6%). Kier reports some big new business wins, such as additional space at HMP Northumberland (>£100m) and four education projects worth c.£210m.  Clearly it’s natural for a large contractor like Kier to be working on such large projects. But I think projects such as these do provide some perspective on this management claim that an “average order size of c.£20m” in Construction helps to limit “our exposure in the event a project does not go to plan”. I am not sure the real level of project-specific risk in Kier’s construction business is quite so reassuring as this. Even so, the group’s Construction business does seem to be performing well at the moment. The change in mix to improve profitability is clearly a good development.

Looking ahead, the divisional order book is £4.5bn, with 95% of FY26 revenue already secured.

Property: slightly unusually in this sector, Kier also has its own property development business. This develops a mix of industrial and residential property and had a relatively good year, with revenue of £38m and an adjusted operating profit of £12.2m.

(The FY24 figures of £71m and £6.2m were distorted by a large one-off sale at seemingly much lower returns.)

Return on capital employed in property was still low at 6.7%, but the company says that following recapitalisation, this division is on track to achieve a “consistent ROCE of c.15%” by FY28.

Balance sheet & Cash Flow

Average month-end net debt halved to £49m last year, while Kier ended the year with an improved net cash balance of £204m.  Year-end window dressing and big working capital movements are typical in this sector, so it’s the average month-end figure that’s more useful here. However, looking at the accounts, I’m not sure how much indebtedness really decreased last year.  The balance sheet shows gross debt of £1,485.3m at year end, 6% higher than the FY24 gross debt figure of £1,402m.  The reduction in net debt reflects an 8% increase in year-end net cash to £1,689.4m.

In addition, the company reports today that suppliers are paid in an average of 34 days. Looking at the outstanding trade payables suggests a slightly different view, though. Average FY25 payables of £1,108m represent almost 30% of cost of sales of £3,746.3m. Said differently, this seems to suggest it takes over 100 days for Kier to turnover its payables, on average.  I am sure the 34 day claim is correct, so I wonder how representative the year-end balance sheet really is of Kier’s year-round financial position.

Free cash flow

on a related note, I can’t help feeling that Kier’s calculation of free cash flow is also a little generous.  The company reports a free cash flow figure of £155m today, but I can’t get close to this. Working down the cash flow statement gives me a free cash flow sum of around £86m, including all finance, tax and lease costs. This is actually a pretty respectable result, compared to reported net profit of £56.4m. My figure is also a near match to the £77m total I get by adding the reduction in net debt (£37m), dividends (£24.1m) and share buybacks (£16.1m).

Outlook

I’m slightly sceptical about how fast Kier is really deleveraging. But my overall impression of these results is that they are fine and do not highlight any serious concerns.  Looking ahead, departing CEO Andrew Davies says the group has already secured 91% of FY26 revenue and around 70% of expected FY27 revenue.  Perhaps understandably, he is confident in the group’s momentum and upbeat about prospects for the year ahead:

Building on our outperformance in FY25, the Group has started the current financial year well and for FY26 is trading slightly ahead of the Board's expectations.

I don’t have access to any updated broker estimates today, but I would guess that consensus estimates could rise by perhaps 2%-4% after today’s results are digested. FY26 estimates have already been (modestly) upgraded on two occasions over the last 12 months – albeit they remain below expectations from early 2024:

b930aef4-6369-4e41-9577-4312234d09e3.png

Roland’s view

Today’s results leave Kier trading on a P/E of around nine, with a forecast yield of 3.8%. For a low-margin construction group that generated a 12% ROCE last year, I think this is probably a fair valuation. The company says it’s on track to increase adjusted operating margin from 3.9% to “4.0%-4.5% over the next three to five years. Any improvement in margins should feed through to improvement in cash generation. I can’t deny the momentum here, but I’m a little disappointed Kier is still operating through the year in a net debt position. Achieving average net cash remains a long-term goal, however.

I need to decide whether to upgrade by one notch to AMBER/GREEN, or maintain my previous AMBER (neutral) view. I’m inclined to be neutral, in part because of my caution about this sector. But given the evidence we have about the benefit of repeated upgrades, I can’t ignore today’s improved guidance. An encouraging pipeline of higher-margin infrastructure work in the water utility sector also looks promising.  With slight reluctance, I have moved our view up by one notch to AMBER/GREEN.

Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

47 comments


Avatar for Subparstockpicks

Comprehensive response, thanks! You know the name much better than me.. I'd only argue that deleveraging will always provides benefits for the business (by reducing liquidity and solvency risks) whereas buybacks essentially operate as a leveraged re-investment within the company. Yes, it can provide higher returns for shareholders, but that requires the company to time it well. And in my experience most companies buy low and sell high, when it comes to share buybacks. 

0
Avatar for tareynolds1965

What are the chances  of Brickability (LON:BRCK) targeting Michelmersh Brick Holdings (LON:MBH) ?. I am curious because I hold Michelmersh Brick Holdings (LON:MBH) . There is also a connection between the two  companies as current CEO Frank Hanna joined Brickability (LON:BRCK) from Michelmersh Brick Holdings (LON:MBH) . The construction and housebuilding sectors have been stagnant for a while, but recent updates and results seem cautiously optimistic.

0
Avatar for johnMulvihill

It would be nice to get your view on kromek in the light of its recent final results . A stockrank of 20 hardly seems justified in the light of those results with rev up 37% with pat of 3.1 mill ( gbp) it's first landmark contract with substantial payment on account ,significant debt reduction . Gross margin up signif. 

2
Avatar for abtan

Kromek (LON:KMK) 

Hi JohnMulvihill

A very brief comment on Kromek since I was looking at it this morning.

You're right, this morning's results looked excellent.

However, it was largely influenced by a one-off $25m/£16.5m contract win with Siemen's Health.

4c98d9c9-7c28-433a-82a6-a25c4f3f9ed3.png


If you strip away this £16.5m from the £20.27m, that's a material year-on-year decrease in Advanced Imaging revenues.

That's in addition to the material decrease in CBRN/Bio revenues from 2024 to 2025.

The company spoke about top line improvements for 2026, but given the above decreases I'm not convinced by the story yet. 

A few more wins, similar to the Siemens deal, would certainly make me reconsider this position, however, I think it's worth adding that I'm definitely not an expert on their tech so I have no idea how likely this is.

Cheers

A

19
Avatar for JamesPope44

In terms of the YoY of Advanced Imaging there was this note from the RNS "While discussions leading to this agreement temporarily affected regular sales activity, Kromek is now seeing renewed commercial momentum returning across this division, including ramping up deliveries under the contract with Spectrum Dynamics and demonstrating commercial traction beyond the Siemens Healthineers agreement."

Hopefully they can support both sales cycle in the future - ie, "regular sales activity and large contract wins". You wouldn't want them to be mutually exclusive. 

I recently did some research on when medical operators lifecycle of CT Scanners reach end of life. This is the technology that PCCT will replace. A typical lifecycle is 7-10 years (10-12 in low volume hospitals). I dont have my research at hand but from memory the peak period when hospitals are going to decide whether to remain with the multi-detectors scanners or roll into PCCT (which is the ultimate end use demand for Kromek technology) is 2027-2031. Before people worry that is years away....the hospitals would be planning for 2-3 ahead of this cycle. You would see revenues recognised ahead of the adoption. So, if the technology is as good as suggested (and Siemans deal should act as a strong indicator to the validation) then we are moving into a phase of much large macro demand. None of these large deals are reflected in the house brokers forecasts, but at an investors day back in May Kromek were talking up revenues of £60m in the next few years (please keep me honest here, as again I need to go back to my research notes).  The former ties up with the larger demand from greater demand for this advanced imaging scanners in high volume hospitals. 

6
Avatar for abtan

Kromek (LON:KMK)

Hi James

Thanks very much for that.

You've basically highlighted my biggest flaw when investing in companies with any level of sophistication - I have no idea who has the best tech/product or what will still be around in 10 years.

On your point about 2027 not being far away I believe there was mention of a trial with a hospital in Newcastle that started recently.


On your comment regarding "temporarily [affecting] regular sales activity" yes I did see this. 

I thought it was worrying that the company has to choose between regular sales activity or negotiating a new contracts. Surely it should be set up to do both? Maybe it will be soon.

Thanks again

A

3
Avatar for Rusty2

Mark, you have the incorrect ticker in the table, for SThree (LON:STEM) shares are down 20%, would welcome some comments.

2
Avatar for Mark Simpson

thanks, will correct, and take a look.

0
Avatar for Subparstockpicks

LON:BRCK

Add in net debt and it's trading at a debt adjusted P/E of 8 x 2027 earnings. Seems expensive, unless they are dramatically paying down the debt load?

9
Avatar for yiannos1

Correct!

and they are not paying it down.

All the best 

6
Avatar for rmillaree

Brickability (LON:BRCK)

and they are not paying it down.

i think the reasons for that are at least clear and out in the open - note they also had £37 mill of deferred payments due ref the 2 acquisitions. Those payments are structured over 3 years - so probably just over 1 year to go before that significant cashflow commitment is out of the way - at which stage they should in theory "if they have no nasties"  quickly be able to tackle the remaining debt mountain fairly quickly - should they choose not to allocated excess cashflow elsewhere.  Its fair comment to say that they have everything to prove in that regard though.

 imho them doing nothing more than concentrating on delivering nice clean 12 month set of figures ye 31/3/2026 is what will show to the market that they have ability to quickly reduce debt once 3 year period is up. In that regard we will have to wait and see how they are progressing.

6
Avatar for yiannos1

Brickability (LON:BRCK)

Debt will not come down.

The board will have to go for more acquisitions as their growth is close to zero.

All the best 

2
Avatar for rmillaree

Brickability (LON:BRCK)

The board will have to go for more acquisitions as their growth is close to zero.

Personally i would love them to simply concentrate on the current business over the next 18 months to derisk the balance sheet - time will tell though as to when their next acquisition is and how big it will be. You are probably right that they will be on the lookout for acquisitions at the right time for the right price - if nothing else though i would expect any furtehr acquisitions should bring future decent profits - i understand why the jury is out here in that regard clean ye 31/3/2026 resulkts or not is probably good time to judge how they are doing with what they have.


2
Avatar for Subparstockpicks

Interesting if they do delever, then the equity looks cheap. Deleveraging increases equity value more efficiently than share buy backs or dividends.

EV = market cap + net debt, so lower net debt = higher market cap (to equal the same enterprise value).

However, the risk is management do another acquisition. Either which way you should adjust the current sub 6 P/E for the debt though!

0
Avatar for rmillaree

Brickability (LON:BRCK)

Interesting if they do delever,

Without future  reductions in expected profits or additional acquisitoons (yiannos is right to point out that often management have fixed mindset of constant acquisitions as soon as the finances will allow!) - its a racing certaity that the debt/deferred liabilitiews combo will reduce pretty quickly. Perhaps not as fast as i would like or predict but if they make £30 mill pa - and say have less than £3mill pa exceptionals there is nowheer else for the cash to go other thna flow through to the bottom line. the reduction in lack of reduction in debt temporarily will be solely due to the fact the deferred considerations and paid over the rshorter timeframe - so fisrt 3 years its probably more loaded there - from the 3 year point that gone and all teh cashflow can go to debt. 

Deleveraging increases equity value more efficiently than share buy backs or dividends.

Not necessarily its hard to beat buybacks if (1) you are buying back at cheap earnings multiple (2) and earnings in then future will be better than the now. Sometimes that takes time to flow through though - so temporarily finance costs will be higher and earnings lower - but that should drop out the picture in a few years but there will be future benefit. It might be a close call if financing costs and debt are high though.

What is key overall and yiannos is right to be slightly skeptical  of is teh question  are they continually going down the acquisition trail to cover up the fact that the current business they are managing are going to go backwards ref future performace - eg could they fundamentally be failijng to generate organic growth over thne cycle of the business. Time will tell whether the established parts of the busines bounce back or not. But many constant acquisition companies do have problems getting the basics of the established buisness right so they can keep profits going in line with inflation. I woudl say cladding is spivvy - but they have spent close to £100 mill and this specific niche clearly has short/medium term tailwinds that probbaly wont alst forever.

EV = market cap + net debt, so lower net debt = higher market cap (to equal the same enterprise value). - yes - but if you can reduce sharecount by 25% with buybacks - suffer extra finance costs and come out making hiogher level of profits in 5 years then share buybacks might turn out to have been the best use of money - particularly if you are only paying pe of 6/7 to buy shares. Companies that increase future profits and buy back shares at modeest valuation - always do well - it only goes wrong when the underlying fundamentals ref future profits go wrong.

However, the risk is management do another acquisition. Either which way you should adjust the current sub 6 P/E for the debt though!

Exactly - but as long as they can drive the current business units going forward ecquisitions shouldnt necessarily fail. only time will tell if as the company hope volumes ref non cladding work returns and the established stuff refinds its mojo - they also ned to ensure that cladding easy money doesnt dry up too.

One caveat here debt is real and certainly derves discount - but so to does amounts owed out in deferred consideration as thats simply interst free debt - imho though unlike some companies who would take 10 years plus to make any headway on debt  - this company shoudl be able to pay down debt quickly - so personally i will penalise this company less than say a vodafone where it might take 10 years plus to make debt inroads.

Overall i think the market price isnt far from being fair - i think on the balance of probabilities they will do well - but i only have small stake here so i wouldnt say its a high conviction punt. I dont believe anyone for being sceptical ref companies that pneed to pay top dollar to buy in future profits.

2
Avatar for Bouden54

And remember earnings are heavily adjusted - you need to be comfortable with these. I would personally take a bit off the EPS figures for prudence.

0
Avatar for rmillaree

Brickability (LON:BRCK)

In theory here the debt shouldnt be much more than the equivalent of an hp agrment to purchasae a new van where you spread the payments over 4 years.

After 4 years debt should be fully paid down (all other things being equal) - and the finance costs that will have been a drag on earnings should be gone.

Thats how the good acquisition companies work - simply get future profits cashflow to do the job using a  bit of your own cash flow too.

 Part of the reasons why i sold up here originally was the second chunky acquisition  my worry was  that they couldnt afford anything to go wrong with the acquisitions in the first couple of years when debt (plus defered amounts owed) was high.  We arent quite at the 2 year mark yet - but almost 2 years has passed withn acquired units doing ok and price has dropped back down which has tempted me back in.

Lets look at expected net profit this year and next thats 28 mill and 31.5 mill (ok 2027 forecasts might look a stretch at present)

say £13 mill pa for dividends 

 thats £33 mill surpus profit over the 2 year period 

note there should be approx £20 mill of amortisation costs charged to the p&l over 2 years - so presuming the above stocky profits factor this non cash charge in that adjusts back up to £53 mill . that stack up prety well to the £56 mill net debt.

Note they did have a total of £37 million of deferred payments ref two acquisitions that was paid over 3 years - so some of the profits will be needed to pay that down rather than debt ref amounts still o/s which are likley pretty chunky.

So perhaps not fully paid of within 4 years here bearing in mind we are nearly 2 years into the process - but in theory they should have some good cashflow coming in if its not syphoned off for other reasons and could if they had no nasties and diver all cashflow pay off the lot (working capital - exceptional costs - further acquisitions - etc)

9
Avatar for af20001

Reassuring update from Focusrite (LON:TUNE), especially as they mention the U.S. tariffs haven't had a material impact. That's a bit of a surprise considering the price rises that resulted from them.

2
Avatar for yiannos1

Somero Enterprises (LON:SOM)

Always had my doubts about their story…… and it is obvious that they will have at least another one/two profit warnings.

However, Regent are increasing their stake and they have already been involved in some takeovers. 

I do not hold and not getting involved at current prices, but I believe Somero Enterprises (LON:SOM) will be acquired over the next 18 months by Regent.

All the best 

27
Avatar for yiannos1

Brickability (LON:BRCK)

Mentioned today so here are my brief thoughts.

For any experienced investor, it is obvious that this sector should always be priced at around current/forward PE due to its cyclical nature. 

There is no difference between this sector, the banking sector and the oil sector in relation to their valuation.

House builders (UK) will offer better returns when (if) the sector recovers. Have my doubts in the near future.

All the best 

35
Avatar for Mark Simpson

If we take it as a given that this is a cyclical stock (I do), the big question is where are we in the cycle? If we are close to a cyclical high then being on a P/E of around 6 may may make a stock overvalued, as they will have been over-earning recently. Cyclical stocks always look superficially cheap at the top of the cycle and expensive at the bottom. However, if this is closer to the bottom than the top and the stock still looks cheap, this may be a great opportunity.

I don't agree with your argument that a cyclical stock should always be on a low multiple wherever we are in the cycle. It means that the value of a cyclical stock takes huge wild gyrations in fair value as the earnings are exaggerated by the cyclical market conditions. Instead, I believe that the market tends to suffer from recency bias and get excited when cyclical stocks are trading well, and overly pessimistic when they aren't. Fair value just doesn't move as much as EPS, and they key is to be countercylical, buying when everything is gloomy and selling during the boom times. Of course, picking the exact point in the cycle is almost impossible, but I think its possible to have a general feel for where we are.

My own view is that we are closer to the cyclical bottom  than top, hence if Brickability (LON:BRCK) is generating reasonbles profits and trading at a cheap multiple at the moment, there is scope for it to generate higher EPS in beter market conditions and may be given a higher multiple.

However, I'm a natural contrarian, so would be very interested in your argument that this industry is no longer cyclical and will never see better days. Do you think something has permananetly shifted in UK housebuilding/construction, meaning this is permanently in the doldrums?

22
Avatar for yiannos1

A cyclical stock is a cyclical stock and there is nothing more to add.  It should always be valued as that.  As for the stock in question Brickability (LON:BRCK) is so obvious that they are not growing and they will need to load the company with more debt in a couple of years in order to fund further acquisitions. That’s what boards do to survive!

The whole thing reminded me of BnB’s famous comment about teapots 2-3 years back when Paul was trying desperately to make an investment case about Portmeirion (LON:PMP).  

The world economy is in the initial stage of something spectacular (after the internet revolution) and we are talking about bricks.

Good luck to all holders. 

Last thing I want is for people to be losing money.

All the best 

6
Avatar for raggedtp

What's the something spectacular please, yiannos? 

Would be interested in your opinion if there any UK winners.

Thanks

2
Avatar for yiannos1

I post my own positions (as soon as possible) on the US options activity thread.

All the best

1
Avatar for lemming1

I think he means AI.

1
Avatar for Mark Simpson

I don't think this is true:

A cyclical stock is a cyclical stock and there is nothing more to add.

Applying a consistent earnings mutliple to every cyclical stock across all points in the cycle seems a bit daft to me. As is the idea that anything not involved in a technological revolution is worthess or not worth discussing:

The world economy is in the initial stage of something spectacular (after the internet revolution) and we are talking about bricks.

The long history of stock markets tells us that those who own the type of companies that deal with bricks tend to make money and those who invest based on technological revolution tend to lose money! (On average, and over the long term.) I don't see anything wrong with playing the odds and focussing on the boring and profitable in our coverage, rather than the exciting and new-fangled!

32
Avatar for yiannos1

.

0
Avatar for BnB

The long history of stock markets tells us that those who own the type of companies that deal with bricks tend to make money and those who invest based on technological revolution tend to lose money!

You can prove anything with a carefully curated dataset and time window. However, applied to the last 20 years - a statistically significant length of time and by far the most relevant period - your statement is utter bollocks. One has only to compare the performance of the Nasdaq with any other index, let alone the moribund UK.

From my own experience in public markets, as a buy and hold investor, starting out with an even split of tech, heterogeneous industrials and defensives, 14 of the top 20 performers are software or semis and the other 6 build data centres, cool semiconductor racks or provide highly engineered products.

Many ways to skin a cat, of course, but you're constantly having to find the next value opportunity - and I acknowledge there is a satisfaction in that - while MSFT holders have just had to stay the course, which is 40 years long now.

14
Avatar for rmillaree

Brickability (LON:BRCK)

My own view is that we are closer to the cyclical bottom than top

specifically with regard to the cladding side of stuff that is doing well surely they are pretty much near the top now - once the extended backlog of known work is gone it would make sense that work and easy profits might become harder to generate. Thats speculation on my part - it does seem that for now that shouldnt be an issue. The acquired entities werte making ridiculously good margins pre acquisition - margins like that should not be expected to be sustained forever.

However, I'm a natural contrarian, so would be very interested in your argument that this industry is no longer cyclical and will never see better days.

yiannos specifically agreed it is a cyclical industy - just that there was no near term evidence of bounce yet ref housebuillding and the like. In that regard there is little evidence of better times around the corner so its a pretty logical stance as things stand - thats despite the promises made by the powers that be - there is a dettachment here - powers that be have promised shed loads of new homes- they massively need to get their finger out if they want to have condistions where that will happen.

7
Avatar for Tresawle

Kromek (KMK)

Good(ish) results impaired in my view by the award of substantial bonuses for 2 directors for the Siemens contract largely in the form of options at 1p. 

8
Avatar for JamesPope44

I am in two minds about the option awards. My understanding is that number of options is equivalent to circa £215k each at todays value. They have delivered a game changing deal, so should probably be awarded for that. I suppose the issue with Kromek is that its off the back of a decade of under performance..... so it feels a bit trigger happy for the award! It would have been nice to have seen maybe a second deal considering the last decade before a juicy award.....but....if this is a sign of things to come I am not going to lose any sleep over it. You would also expect them to sit on the options for a while so not hitting cashflow just yet.

1
Avatar for jonno

Brickability (LON:BRCK)

To echo what RevB has said; it is difficult to reconcile the share price versus the company's performance. This morning's AGM up date was as good as could be expected, given the current impasse in the construction and the housing market.

As far as I can tell Brickability (LON:BRCK) in common with its peer group has referenced challenging markets but unlike many of its contemporaries it continues to trade in line.  The share price and current forecasts are for a yield greater than the PE.  Debt is a little high but nonetheless am I missing part of the puzzle.

As you may have guessed I hold.  Views and thoughts welcome.

16
Avatar for topvest

Pollen Street (LON:POLN) - it would be good if this could be covered. Asset manager earnings doubled reflecting operational leverage as AUM ramp up. This looks to be flying!

29
Avatar for Nanotrader09

What's with the measly dividend increase, my only gripe.Pollen Street (LON:POLN)

9
Avatar for The Phoenix

Seconded Topvest they come up on my garp screen seem to tick all the boxes, the only thing that has held me off buying is that part of the business involves buying IFA practices and with the new consumer duty rulings a lot of acquirers have been hit with fines for the client reviews not being completed by the companies they have bought.

 

0
Avatar for Muzzer

Great numbers - would be good to see some analysis please.

2
Avatar for Revs8

Brickability (LON:BRCK) reiterating in line guidance. I am not sure what the market expectations are but, if the Stockopedia forecasts are based on guidance, then Brickability (LON:BRCK) has a forward PE of between 6 and 7 paying a dividend of between 6 and 7%. Surely this is bargain territory? Have I missed something? I hold. 

28
Avatar for rmillaree

Brickability (LON:BRCK)

Surely this is bargain territory? Have I missed something? I hold.

Its unloved by the market - at present its probably a hard sell.

Directors happy to sell 4 million shares recently - on top of boat load of other sells going back to last August with no buying.

No uptick in prospects yet - the opposite as propsects have worsened overall since the back end of last year.

They have taken on  boat load of debt ref 2 latest acquisitions - so debt over £50 mill.

Latest acquisitions have great backlog of historical work for the medium term - but what are long term prospects in the sector once backlog of historical remedial stuff starts to dry up? Its clearly current cash cow in that regard - but how long will that cash cow hang around. There must have been many new enbtants to the market with the current backlogs in place.

annual accounts dont set the world alight from cleanness point of view (nothing specifically sketchy)

eg gross profit of £120 mill

adjusted pre tax profit £37.8 mill.

bottom line pre tax profit £6.5 mill.

many other companies in sector on similar cheap rating - some of which have less debt.

Personally i have bought back in here recently - 55p seems a reasonable entry price. Its not a high conviction hold i must admit.

Annoying update today despite it being "good news that they are still on track"  -  they couldnt even be bothered to tell us what the expectations they are on target to meet actually are. And being on track ref EBITDA is only half  the story - would be nice if if they concentreated on the real i am number - ie profit. Hey ho they do take the trouble to clarify what EBITDA means - cheers chaps and ladies.

18
Avatar for GloucesterBob

Personal group (LON:PGH) appears to have smacked everything out of the park. All indicators up in double digits, high double digits in most cases, including dividend. Roland is a fan, are you Mark?

24
Avatar for tony axon

Spot on Bob, I too am a very happy investor ,about 30% up since investing here earlier this year. It came to my attention thro' my CDREFs sieves.  Another plus [found out after I'd bought it ] Simon Thompson of IC is a fan ,so his writeups add further investor interest. Tony

16
Avatar for iwright7

It looks to me like Personal group (LON:PGH)  "in line" H1 is playing it cool, with a view to a materially ahead with its next YE trading update in January;  i.e. a repeat of last year's RNSs .  

12
Avatar for topvest

Personal group (LON:PGH) - yes, great results. They seem to have real momentum. Cash plan and digital insurance offerings not yet in the numbers. 

8
Avatar for sevenccc

The only worry for me with Personal group (LON:PGH) is the £100m sales, £30m EBITDA, etc targets for 2030. If I recall correctly there have been several companies over the last 5 years that have espoused these ambitious targets and failed ignominiously. I'm sure I heard this from Genedrive (LON:GDR) and SysGroup (LON:SYS) under, not surprisingly, former CEOs. 

I hold here and wish them every success. Pleased with the numbers today but did topslice ahead of this as the sp had moved up to my target for next year - 375p-400p. That was 15-16x earnings at that point. Echo Roland in being pleased with being recognised and rewarded for continuing to hold some shares with increase in dividend rather than buybacks. 

1
Avatar for grumpy5

Bought after watching a v solid presentation at Mello Chiswick. My first reading is that they are underplaying things by not letting FY forecasts drift up.

4
Avatar for yiannos1

Personal group (LON:PGH)

Great company especially when trading around 170p.

First came to my attention by Wolfie and after a quick glance at their accounts it was so obvious……

Wolfie come back!

All the best

8
Avatar for The Phoenix

Agreed real shame he left would love to see him back over on Stocko

5
Avatar for The Boon Fund

I sold out recently at Personal group (LON:PGH) at c360p, having held since 170p.

For me, I was getting worried that:

  • New client wins were slowing down. This is the "top of the funnel" required to drive growth.
  • Penetration into each client's employee base looked quite high already, compared to historic. Without a step-change in the way they sell, or what they sell, I doubted they could increase further with just "incremental operational optimisations" in selling

Today's update is somewhat positive on both. They claim to keep winning new clients, and a strong pipeline, albeit no numbers provided, or even big client marquee names mentioned. On penetration they did give numbers here, I think 13% to 13.7%, which is good to see.

Anyways, for me I'm out. 19x forward FY Dec25 PE for a people-based business, and slow growth cycle (first they have to get the client, then they have to go in and get the employees, and then the fixed cost is always up front to the recurring insurance payments) - for me seems a bit too high a PE valuation for this type of model. On top of the regulatory risks of insurance (and you can buy other general insurers at less than 10x).

11
Get the free newsletter